Guidelines for the programmatic management of drug-resistant tuberculosis / WHO - World Health Organization
- xxi, 247 p. ; 24 x 16 cm.
- WHO/HTM/TB/2008.402 .
Foreword to the 2008 emergency updated edition -- Background information on DR-TB -- Framework for effectie control of DR-TB -- Political commitment and coordination -- Definitions: case registration, bacteriology and treatment outcomes -- Case-finding strategies -- Laboratory aspects -- Treatment strategies for MDR-TB and XDR-TB -- Mono-resistant and poly-resistante strains -- Treatment of DR-TB in especial conditions and situations -- DR-TB and HIV infection -- Initial evaluation, monitoring of treatment and management of adverse effects -- Treatment delivery and community-based DR-TB support -- Management of patients after MDR-TB treatment failure -- Management of contatcs of MDR-TB patients -- Drug resistance and infection control -- Human resources : training and staffing -- Management of second-line antrituberculosis drugs -- Category IV recording and reporting system -- Managing DR-TB through patient-centred care -- Annexes -- Drug informations sheets -- Weight based dosing of drugs for adults -- Suggestions for further reading -- Legislation, human rights and parients' rights in ruberculosis prevention and control -- Use of experimental drugs outside of clinical trials (compassionate use) -- Methodology -- Forms -- Index --
9789241547581
Agentes antituberculares--administración y dosificación
Infeccion por vih--terapia de droga
Infeccion por vih--quimioterapia
Terapia antirretroviral altamente activa
Tuberculosis resistente a la droga--quimioterapia
Tuberculosis resistente a la droga--terapia de droga
Tuberculosis resistente a multiples drogas--prevención y control
Medicina
Salud
616.995 / W551g
Foreword to the 2008 emergency updated edition -- Background information on DR-TB -- Framework for effectie control of DR-TB -- Political commitment and coordination -- Definitions: case registration, bacteriology and treatment outcomes -- Case-finding strategies -- Laboratory aspects -- Treatment strategies for MDR-TB and XDR-TB -- Mono-resistant and poly-resistante strains -- Treatment of DR-TB in especial conditions and situations -- DR-TB and HIV infection -- Initial evaluation, monitoring of treatment and management of adverse effects -- Treatment delivery and community-based DR-TB support -- Management of patients after MDR-TB treatment failure -- Management of contatcs of MDR-TB patients -- Drug resistance and infection control -- Human resources : training and staffing -- Management of second-line antrituberculosis drugs -- Category IV recording and reporting system -- Managing DR-TB through patient-centred care -- Annexes -- Drug informations sheets -- Weight based dosing of drugs for adults -- Suggestions for further reading -- Legislation, human rights and parients' rights in ruberculosis prevention and control -- Use of experimental drugs outside of clinical trials (compassionate use) -- Methodology -- Forms -- Index --
9789241547581
Agentes antituberculares--administración y dosificación
Infeccion por vih--terapia de droga
Infeccion por vih--quimioterapia
Terapia antirretroviral altamente activa
Tuberculosis resistente a la droga--quimioterapia
Tuberculosis resistente a la droga--terapia de droga
Tuberculosis resistente a multiples drogas--prevención y control
Medicina
Salud
616.995 / W551g